Ovid TherapeuticsOVID
13F holders, Q2 2025 (June 30)71holders −11
17new positions
27sold out
3famous investors
$0.33avg. 13F price*
At the end of Q2 2025, 71 institutions reported holding Ovid Therapeutics Inc. (OVID) in their 13F filings, down 11 from Q1 2025. 17 opened new positions and 27 sold out. The largest holders were Takeda Pharmaceutical Co. Ltd. ($2.5M), BVF Inc. ($1.3M) and Vanguard Group Inc. ($870K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Cliff Asness (0.0% of AQR Capital Management's portfolio).
- Company
- Ovid Therapeutics Inc.
- CUSIP
- 690469101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 17 | $755K |
| Exits | 27 | $486K |
All 13F filers, Q1 2025 → Q2 2025: 4,242,885 shares bought and 14,677,353 shares sold, net −10,434,468 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 71 holders
| Takeda Pharmaceutical Co. Ltd. | 12.71% | No change | 7,531,996 | $2.5M |
| BVF Inc. | 0.05% | No change | 3,853,818 | $1.3M |
| Vanguard Group Inc. | 0.00% | Reduce -15.2% | 2,636,115 | $870K |
| Sio Capital Management, LLC | 0.30% | No change | 2,232,000 | $736K |
| Acadian Asset Management LLC | 0.00% | Add +1.0% | 2,108,336 | $693K |
| Renaissance Technologies | 0.00% | Add +104.7% | 2,095,309 | $691K |
| Kennedy Capital Management LLC | 0.01% | Reduce -13.3% | 1,502,329 | $496K |
| Driehaus Capital Management LLC | 0.00% | No change | 1,400,191 | $462K |
| BlackRock, Inc. | 0.00% | Reduce -64.5% | 1,369,010 | $452K |
| Madison Avenue Partners, LP | 0.03% | Reduce -46.8% | 1,311,362 | $433K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 1,150,000 | $379K |
| Millennium Management | 0.00% | New | 1,052,334 | $347K |
| Wells Fargo & Company | 0.00% | Reduce -3.0% | 763,114 | $252K |
| Gsa Capital Partners LLP | 0.02% | Add +68.6% | 742,190 | $245K |
| TLS Advisors LLC | 0.70% | No change | 680,967 | $225K |
| Affinity Asset Advisors, LLC | 0.03% | No change | 667,516 | $220K |
| Geode Capital Management, LLC | 0.00% | Reduce -51.7% | 643,335 | $212K |
| Rosalind Advisors, Inc. | 0.08% | New | 500,000 | $165K |
| Rubric Capital Management LP | 0.00% | Reduce -91.0% | 478,533 | $158K |
| Assenagon Asset Management S.A. | 0.00% | Reduce -22.3% | 435,620 | $144K |
| Goldman Sachs Group Inc. | 0.00% | Add +171.8% | 283,824 | $94K |
| Susquehanna International Group, LLP | 0.00% | Add +177.1% | 230,245 | $76K |
| State Street Corp. | 0.00% | Reduce -83.5% | 227,033 | $75K |
| Squarepoint Ops LLC | 0.00% | Reduce -16.7% | 221,126 | $73K |
| Marshall Wace, LLP | 0.00% | New | 164,721 | $54K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | New | 160,306 | $53K |
| Velan Capital Investment Management LP | 0.05% | Add +65.0% | 160,000 | $53K |
| Jane Street Group, LLC | 0.00% | New | 142,597 | $47K |
| HRT Financial LP | 0.00% | Add +381.9% | 123,316 | $40K |
| ADAR1 Capital Management, LLC | 0.01% | No change | 115,867 | $38K |
| Northern Trust Corp. | 0.00% | Reduce -76.6% | 99,118 | $33K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 95,434 | $31K |
| Empowered Funds, LLC | 0.00% | No change | 91,234 | $30K |
| XTX Topco Ltd | 0.00% | Reduce -15.8% | 78,420 | $26K |
| Qube Research & Technologies Ltd | 0.00% | New | 72,741 | $24K |
| Bank of New York Mellon Corp | 0.00% | Reduce -65.2% | 57,697 | $19K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +116.0% | 51,520 | $17K |
| FMR LLC | 0.00% | Add +52.1% | 46,988 | $16K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.00% | New | 38,382 | $13K |
| Aaron Wealth Advisors LLC | 0.00% | New | 38,259 | $13K |
| Allspring Global Investments Holdings, LLC | 0.00% | New | 38,287 | $12K |
| Abel Hall, LLC | 0.00% | Add +216.0% | 32,348 | $11K |
| First Manhattan Co. Llc. | 0.00% | No change | 26,000 | $9K |
| Blair William & Co. | 0.00% | Reduce -4.1% | 22,089 | $7K |
| UBS Group AG | 0.00% | Reduce -19.6% | 21,669 | $7K |
| HSBC Holdings PLC | 0.00% | New | 19,220 | $6K |
| Avantax Advisory Services, Inc. | 0.00% | New | 17,000 | $6K |
| Newman Dignan & Sheerar, Inc. | 0.00% | No change | 16,522 | $5K |
| AQR Capital Management | 0.00% | Add +1.6% | 15,705 | $5K |
| Bank of America Corp. | 0.00% | Reduce -53.0% | 14,908 | $5K |
| PFG Investments, LLC | 0.00% | New | 13,975 | $5K |
| Jump Financial, LLC | 0.00% | New | 13,718 | $5K |
| Virtu Financial LLC | 0.00% | New | 12,664 | $4K |
| Citigroup Inc. | 0.00% | Reduce -73.6% | 11,411 | $4K |
| Morgan Stanley | 0.00% | Reduce -87.2% | 10,565 | $3K |
| Royal Bank of Canada | 0.00% | Add +17.4% | 6,778 | $2K |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.5% | 5,447 | $2K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 3,874 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | Add +487.8% | 2,351 | $776 |
| Atlantic Union Bankshares Corp | 0.00% | New | 2,300 | $759 |
| Point72 (DIFC) Ltd | 0.00% | New | 1,301 | $429 |
| PNC Financial Services Group, Inc. | 0.00% | Add +14950.0% | 903 | $298 |
| SBI Securities Co., Ltd. | 0.00% | No change | 884 | $292 |
| BNP Paribas Financial Markets | 0.00% | Reduce -98.7% | 867 | $286 |
| Barclays PLC | 0.00% | Reduce -99.9% | 71 | $23 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 30 | $10 |
| EverSource Wealth Advisors, LLC | 0.00% | Add +41.2% | 24 | $8 |
| True Wealth Design, LLC | 0.00% | Reduce -75.0% | 8 | $3 |
| Sound Income Strategies, LLC | 0.00% | No change | 6 | $2 |
| Osaic Holdings, Inc. | 0.00% | No change | 5 | $1 |
| Cwm, LLC | 0.00% | Add +3.9% | 1,506 | $0 |
"% of holder's portfolio" is OVID's weight in each manager's 13F, not the share of Ovid Therapeutics Inc. the manager owns.